Weight-loss drug awaiting FDA approval combines antidepressant, addiction medications

by Stasia Thompson

On Wednesday, June 11, a new prescription weight-loss medication that combines a popular antidepressant with a medication for addiction will be reviewed by the Federal Drug Administration (FDA) for potential approval.

Losing and keeping it off is not as easy as simply popping the right pill, but medications can be a part of a healthy diet, said an internationally recognized weight-loss specialist.

"Prescription drugs are no substitute for low-fat, high-fiber balanced diets coupled with , but medication can help increase weight loss in some people," said Bipan Chand, MD, FACS, FASMBS, FASGE, director of the Loyola Center for Metabolic Surgery & Bariatric Care.

Americans spend an estimated $20 billion annually on weight-loss products, including medications.

The new prescription medication is a combination of two FDA-approved drugs, bupropion, an antidepressant, and naltrexone, which reduces the desire for drugs and alcohol. Both have been found to increase weight loss in independent research trials and combining the two in one capsule is believed to create a synergistic effect. In clinical trials, patients taking the new medication while following a diet and exercise program lost more weight than those taking a placebo and following the same diet and exercise regimen.

In a 56-week period, the nonmedicated group lost 11-16 pounds while the medicated patients lost 20- 23 pounds.

In February 2011, the FDA requested a large-scale study of the long-term cardiovascular effects of the drug before considering approval.

"Many medications for various conditions have been found to have weight loss as a side effect, and conversely, many medications can cause weight gain," Chand said. Weight-loss medications commonly involve an appetite suppressant and a metabolism booster. But not all patients can tolerate prescription weight-loss medication.

"Many obese patients are on medication for chronic conditions, such as heart disease, high blood pressure, high cholesterol, depression and diabetes," Chand said. "Adding another medication must be carefully assessed to make sure it has a positive and not a negative effect on the patient's health."

More than two-thirds of American adults are overweight or obese and 1 in 3 American children and teens are considered obese.

"Behavioral therapy, nutrition counseling, physical exercise and as well as medication are all instruments in the weight-loss toolbox," said Chand, who is a board-certified metabolic surgeon at Loyola, an accredited Level 1 facility under the Bariatric Surgery Center Network (BSCN) Accreditation Program of the American College of Surgeons (ACS).

"Bariatric surgery has been the most effective tool in achieving long-term weight loss, which leads to overall improvement in health, reducing or eliminating chronic conditions and medications and increasing years of life," said Chand, who performs bariatric surgeries.

"At Loyola, we treat obesity as a complex disease and design a treatment solution tailored to each patient," Chand said. "Medication may be prescribed but so is meeting with a dietitian to design a better diet, attending support groups for education and encouragement, working with an exercise physiologist to get moving, seeing an internal medicine physician for overall health assessment and monitoring and potentially scheduling for a more permanent solution," Chand said. "Many Loyola weight-loss patients succeed with medication or surgery and many succeed without medication or surgery. Our medical team of board-certified bariatric professionals work together with the patient to find the right solution."

Since opening on July 10, 2012, at Loyola's Melrose Park campus, a multidisciplinary team of bariatric-certified professionals, including surgeons, psychologists, dietitians, exercise physiologists and physicians has cared for hundreds of morbidly obese men, women and children.

Surgical procedures offered by Loyola include laparoscopic adjustable gastric banding, Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy.

The Loyola Center for Metabolic Surgery & Bariatric Care underwent a voluntary evaluation conducted by an independent team of experienced bariatric surgeons. Loyola was deemed to meet the rigorous, nationally recognized standards outlined by the BSCN ACS for:

  • Safety of the bariatric surgery patient
  • Documented, quality surgical outcomes
  • Standards of practice
  • Highly trained and experienced medical professionals
  • Specially designed facilities to accommodate obese patients and their families
  • Comprehensive medical, nutritional and psychological support throughout the treatment process

add to favorites email to friend print save as pdf

Related Stories

Lap band surgery helps combat diabetes

Sep 02, 2013

(Medical Xpress)—A trial of gastric band surgery in overweight people with type 2 diabetes has found the surgery resulted in better outcomes for diabetes and weight loss than standard exercise and diet ...

Recommended for you

Supermaterial gives rejected drugs a new chance

Jul 22, 2014

More than 80 percent of all drug candidates in the pharma R&D suffer from poor solubility and are therefore rejected early in the drug discovery process. Now Uppsala University researchers show that the new ...

Risk of antibiotic overuse in aged care settings

Jul 21, 2014

Antibiotics are being overused in residential aged care facilities (RACFs), and more integrated efforts to improve antibiotic prescribing practices need to be introduced, researchers say. 

Ruconest approved for rare genetic disease

Jul 17, 2014

(HealthDay)—Ruconest has been approved by the U.S. Food and Drug Administration to treat hereditary angioedema, a genetic disease that leads to sudden and potentially fatal swelling of the hands, feet, limbs, face, intestinal ...

NIH system to monitor emerging drug trends

Jul 17, 2014

An innovative National Drug Early Warning System (NDEWS) is being developed to monitor emerging trends that will help health experts respond quickly to potential outbreaks of illicit drugs such as heroin and to identify increased ...

User comments

Adjust slider to filter visible comments by rank

Display comments: newest first

JamesG
not rated yet Jun 11, 2014
20 - 23 pounds in 56 weeks while following a diet and exercise program. That's pretty slow weight loss for over a year and not the slightest bit encouraging to someone who needs to lose 200 lbs or more. This is just big pharma and Loyola University trying to sell a product.